93rd CMEF Kicks Off, AI Empowers Leapfrog Development of China’s Medical Devices

SHANGHAI, April 9 – The 93rd China International Medical Equipment Fair (CMEF) kicked off on April 9, serving as a global benchmark for the healthcare industry. The exhibition focuses on the in-depth integration of cutting-edge technologies such as artificial intelligence (AI) and large models with medical devices, demonstrating that AI is evolving from an auxiliary tool to an inherent capability, reshaping the entire medical service process and driving the leapfrog development of China’s domestic medical device industry.

Industry insiders noted that with the iteration of AI technologies such as generative large models, AI+medical care has fully penetrated all links of the medical industry. Relying on machine learning and natural language processing technologies, it deeply analyzes complex medical data to assist clinical decision-making and optimize diagnosis and treatment processes, with core values of improving medical service quality, enhancing accessibility and reducing costs.

Medical imaging is the most mature track for AI application in the medical field, and many enterprises demonstrated disruptive technological breakthroughs at the exhibition. Neusoft Medical brought its NeuViz P10 photon counting CT, the world’s first wide-body photon counting CT approved by China’s National Medical Products Administration (NMPA) in August 2025, which adopts a revolutionary cadmium zinc telluride (CZT) semiconductor detector to achieve the “photon direct reading” technological breakthrough.

While reducing radiation dose by more than 90%, the device can provide ultra-high-definition images of 50lp/cm, capturing large-range, ultra-high spatial resolution images in a single scan. A Neusoft Medical representative stated that the device’s core value lies in reshaping clinical CT applications, covering areas such as breast examination that traditional CT cannot reach, and AI empowerment has become an inevitable choice as its data volume is 30 to 50 times that of traditional CT.

Many other enterprises also showcased AI-integrated products. Cofoe Medical exhibited five new products including the Galaxy II AI ventilator and Bluetooth-connected atrial fibrillation blood pressure monitor. Zhang Zhiming, Vice Chairman of Cofoe Medical, said the company would increase investment in core technology R&D to promote the upgrading of medical devices towards intelligence and family use.

In the smart health care field, Qimi Technology’s ecological enterprise Qixin Yinian launched two new full-carbon fiber electric wheelchairs, with the lightweight model weighing only 9.2 kg and foldable. Wang Yue, President of Qixin Yinian and Head of Qimi Technology’s Biomedical Industry Cluster, noted that the company focuses on the actual needs of the elderly to promote the scaling and popularization of smart health care.

Major enterprises are also building collaborative ecosystems. Mindray Medical launched seven Qiyuan specialized large models covering critical care, perioperative period and laboratory testing, building the “Qiyuan Ecosystem”. A Mindray Medical representative introduced that its Qiyuan critical care large model can provide treatment suggestions in line with guidelines and complete medical record writing in 1 minute.

The AI+medical care market has huge potential. China Post Securities estimates that the global market size of AI solutions for the medical industry will increase from 13.7 billion US dollars in 2022 to 155.3 billion US dollars in 2030, with a compound annual growth rate of 35.5%. China’s relevant market size is expected to reach 16.83 billion US dollars by 2030.

As of December 5, 2025, a total of 207 AI medical devices in China have obtained Class III registration certificates, with annual approvals exceeding 40 for three consecutive years. The 93rd CMEF fully demonstrates the vigorous development momentum of China’s AI+medical device industry, which not only strengthens the country’s medical and health service capabilities but also contributes Chinese wisdom to the global medical and health industry’s progress.